For some cancers, response rates with immunotherapy will reach 100% within 5 years, said James P. Allison, MD. Achieving that level of response will require tailoring treatment to each patient’s

A significant number of UK managers are unsure of how to speak to their employees about illness and are particularly uncomfortable speaking about cancer, finds a new report. The research

Although melanoma is not the most common form of skin cancer, it is one of the most aggressive. However, unlike many other types of cancer, the patient has a lot

Skin cancer symptoms are most commonly identified by new moles or changes in existing moles on the body. Using the ABCDE moles checklist can help you tell the difference between

There is nothing quite as mood-killing as mentioning the “c” word at a party. No really, you should try it sometime. Next time you are out at a bar or

Oxford BioDynamics Plc (LON:OBD), one of the largest spin-out companies from Oxford University has expanded further at Oxford Business Park. The business, which is an existing customer of the Park

Oxford BioDynamics Plc (LONOBD) today announced that it has been chosen as an industrial partner in a Horizon 2020 international research and innovation collaboration. The initiative on “Predictive Epigenetics” (PEP-NET),

Amyotrophic lateral sclerosis’ toll on the thinking abilities and behavior of patients is as progressive and damaging as the disease’s physical toll, researchers in the U.K. report, with  ALS-specific cognitive and

Combining structural brain imaging with molecular and clinical biomarkers allows for a detailed assessment of a patient’s clinical state, regardless of age and amyotrophic lateral sclerosis progression, a new study suggests. The

Autoimmune arthritis is the name given to a group of arthritis types where a person’s immune system attacks itself. The most common example is rheumatoid arthritis. When the immune system